INOVIQ Ltd (ASX:IIQ – Get Rating) insider Philip (Phil) Powell acquired 20,000 shares of INOVIQ stock in a transaction that occurred on Friday, May 13th. The shares were purchased at an average cost of A$0.53 ($0.37) per share, with a total value of A$10,620.00 ($7,426.57).
Philip (Phil) Powell also recently made the following trade(s):
- On Monday, May 2nd, Philip (Phil) Powell bought 50,000 shares of INOVIQ stock. The shares were acquired at an average cost of A$0.58 ($0.41) per share, for a total transaction of A$29,000.00 ($20,279.72).
The company has a debt-to-equity ratio of 2.60, a quick ratio of 16.29 and a current ratio of 16.70.
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes.
See Also
- The Institutions Are Capping Gains In Take-Two Interactive
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
- Time to Ride These 3 Mid Cap Momentum Plays
- Beware The Rebound In Home Depot
Receive News & Ratings for INOVIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INOVIQ and related companies with MarketBeat.com's FREE daily email newsletter.
